Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Versanis Bio Announces Completion of Enrollment of the BELIEVE Phase 2b ...
Versanis Bio Announces $70 Million Series A Financing to Advance ...
Versanis Bio CEO and Key Executive Team | Craft.co
Series A - Versanis Bio
Versanis Bio | The Org
Versanis Bio appoints Mark Pruzanski as CEO | Biotechnology | The ...
Eli Lilly to Acquire Versanis Bio in up to $1.925 Billion Deal With ...
Versanis Bio | Forbion
Eli Lilly’s $1.925 Billion Acquisition of Versanis Bio – Global Legal ...
Lilly Completes Acquisition of Versanis Bio for $1.925 Billion
Lilly Completes Acquisition of Versanis Bio – Midwest Region Biotech ...
Lilly expands portfolio with $1.9bn acquisition of Versanis Bio
Lilly adquirirá Versanis Bio para mejorar los resultados de los ...
Eli Lilly To Acquire Versanis Bio - DistilINFO LifeSciences
Eli Lilly boosts obesity portfolio with Versanis Bio acquisition
Lilly Completes Acquisition of Versanis Bio - NORTH AMERICAN BUSINESS
Eli Lilly to acquire Versanis Bio and with it bimagrumab which is in ...
Versanis Bio snags $70M for a ditched Novartis muscle drug, with a ...
Lilly Completes Acquisition of Versanis Bio - Healthcare Global
Kiran Dole - VP, Clinical Operations at Versanis Bio | The Org
Eli Lilly and Company completes acquisition of Versanis Bio
Big Bucks For Obesity Treatments As Eli Lilly Buys Versanis Bio For Up ...
Eli Lilly shares plans to acquire Versanis Bio for $1.9bn
Versanis Bio Appoints Kenneth Attie and Aditya Venugopal to Key ...
Mark Pruzanski - Chairman & CEO at Versanis Bio | The Org
Lilly contro l'obesità: acquisirà l'azienda Versanis Bio - True News.
Versanis Presents Data Demonstrating Bimagrumab Treatment Leads to ...
Lilly to Acquire Versanis | citybiz
Versanis Announces Initiation of the BELIEVE Global Phase 2b Study of ...
The Importance of Weight Loss Quality in Obesity Treatment - Versanis ...
Lilly to Acquire Versanis to Improve Patient Outcomes in ...
Eli Lilly to buy Versanis for up to $1.93 billion in obesity drugs push ...
Versanis Taps Biotech Veteran Pruzanski to Drive Obesity Drug ...
Versanis Bio-Versanis Bio-企业详情-InvestGO数据库-ByDrug-医药魔方数据库
Lilly to Acquire Versanis for up to $1.925b in Cash to Improve Patient ...
Eli Lilly to acquire Versanis in heated race for weight loss drugs
Lilly to Acquire Versanis in $1.9B Deal | Medical Design & Development
Lilly Drops Nearly $1.93B for Versanis to Bolster Weight-Loss Portfolio ...
Eli Lilly Buys Versanis to Boost Its Obesity Drug Portfolio
新锐|7000万美元A轮融资，开发bimagrumab 近日，加利福尼亚州奥克兰， Versanis Bio宣布完成 7000 万美元的 A ...
Lilly bulks up in obesity with $1.93bn Versanis buy | pharmaphorum
Kirkland Advises Eli Lilly on Acquisition of Versanis | News | Kirkland ...
BioCentury - Versanis vet Pruzanski becomes Abcuro’s chair
Obesity drug maker Versanis to be bought by Eli Lilly for $1.9 billion ...
Pfizer’s RSV Vaccine; Versanis's $70M Financing; AC Immune's Alz's Drug
Lilly completes biopharma acquisitions | News | European Pharmaceutical ...
Event Summary - The Importance of Weight Loss Quality in Obesity ...
19.25亿美元！礼来囊获一款新型肥胖疗法医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
礼来完成收购Versanis Bio，获得肥胖疾病创新疗法 - 知乎
降脂又增肌 GLP-1R的“理想搭档”或将出现
Pharmaceutical Technology
减脂肪不减肌肉：礼来19.25亿美元收购Versanis，获得ActRIIA/B抗体 Armstrong 2023年7月14日， 礼来 宣布 ...
Top 10 smartest deals in biopharma
19.25亿美元！礼来收购Versanis Bio，持续加注减肥资产医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
The Importance of Weight Loss Quality in Obesity Treatment - Event ...
Bimagrumab减重22%，减重原理是什么？
Eli Lilly se expandirá en medicamentos para la obesidad con la ...
#pharma #biotech #lifesciences #clinicalresearch #news #pharmiweb ...
又一匹小核酸黑马，诞生了|迈威生物_新浪财经_新浪网
Lilly wraps up acquisition of Versanis, marking the fifth largest ...
6.14亿美元：维立志博CD3/CD19/BCMA通过NewCo出海
高起点全球竞赛，融资超2.6亿美元的国内Biotech
Optimum Strategic Communications on LinkedIn: #patient #cardiometabolic ...
Biotech Activity Without Rate Cuts - M&A, Approvals, and Chapter 11
Bimagrumab: Um novo tratamento potencial para a obesidade e distúrbios ...
Biocon Biologics and Viatris Receive European Commission Approval for ...
19.25 亿美元！礼来收购 Versanis，加注减肥药管线_开发_Insight_治疗
Eli Lilly社、体脂肪を減らす抗体医薬を開発する米Versanis社を買収：日経バイオテクONLINE
减脂增肌靶点 —— ActRII 今年7月， 礼来 以19.25亿美元收购Versanis，随之又一减重潜力靶点浮出水面——ActRII。肌肉 ...
BELIEVE study to assess Bimagrumab as treatment for obesity
버사니스, 시리즈A 7천만弗.."근손실없는 비만치료제" - 바이오스펙테이터
:max_bytes(150000):strip_icc()/GettyImages-5215033141-153705590316488f8d08ef1674246d27.jpg)
